Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Bergmann

Showing results (121-130 of 149) with videos related to

Pageof 15
Sort By:
Medcomm|July 8, 2025
Incidence and Immunopathology of Myositis in Rectal Cancer Patients Treated With Neoadjuvant Immune Checkpoint Inhibitors and Chemoradiotherapy: Findings From the CHINOREC TrialRebecca Zirnbauer, Simon Hametner, Jutta Bergler-Klein, et al.
International Journal of Molecular Sciences|May 14, 2022
The Role of Telocytes and Telocyte-Derived Exosomes in the Development of Thoracic Aortic AneurysmThomas Aschacher, Olivia Aschacher, Katy Schmidt, et al.
Journal of Cancer Research and Clinical Oncology|October 3, 2018
FGF8 induces therapy resistance in neoadjuvantly radiated rectal cancerFelix Harpain, Mohamed A Ahmed, Xenia Hudec, et al.
BMJ Open|January 10, 2020
Preferences for everyday living inventory (PELI): study protocol for piloting a culture-sensitive and setting-specific translated instrument in German care settings (PELI-D)Tobias Ingo Stacke, Johannes Michael Bergmann, Armin Michael Ströbel, et al.
The Journal of Experimental Medicine|November 5, 2016
--LUBAC deficiency perturbs TLR3 signaling to cause immunodeficiency and autoinflammationJulia Zinngrebe, Eva Rieser, Lucia Taraborrelli, et al.
Annals of Surgery|August 7, 2018
Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for Colorectal Cancer Liver MetastasisJagdeep Singh Bhangu, Andrea Beer, Martina Mittlböck, et al.
Nature Communications|March 16, 2025
Milestone in predicting core plasma turbulence: successful multi-channel validation of the gyrokinetic code GENEKlara Höfler, Tobias Görler, Tim Happel, et al.
Plos One|March 9, 2018
A randomized controlled trial-based algorithm for insulin-pump therapy in hyperglycemic patients early after kidney transplantationJohannes M Werzowa, Marcus D Säemann, Alexander Mohl, et al.
Annals of Surgery|March 30, 2002
TP53 genotype but not p53 immunohistochemical result predicts response to preoperative short-term radiotherapy in rectal cancerDaniela Kandioler, Ronald Zwrtek, Carmen Ludwig, et al.
Nature Communications|August 13, 2024
Dysfunctional tumor-infiltrating Vδ1 + T lymphocytes in microsatellite-stable colorectal cancerVictoria Stary, Ram V Pandey, Julia List, et al.
Pageof 15

Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
Medcomm|July 8, 2025
Incidence and Immunopathology of Myositis in Rectal Cancer Patients Treated With Neoadjuvant Immune Checkpoint Inhibitors and Chemoradiotherapy: Findings From the CHINOREC TrialRebecca Zirnbauer, Simon Hametner, Jutta Bergler-Klein, et al.
International Journal of Molecular Sciences|May 14, 2022
The Role of Telocytes and Telocyte-Derived Exosomes in the Development of Thoracic Aortic AneurysmThomas Aschacher, Olivia Aschacher, Katy Schmidt, et al.
Journal of Cancer Research and Clinical Oncology|October 3, 2018
FGF8 induces therapy resistance in neoadjuvantly radiated rectal cancerFelix Harpain, Mohamed A Ahmed, Xenia Hudec, et al.
BMJ Open|January 10, 2020
Preferences for everyday living inventory (PELI): study protocol for piloting a culture-sensitive and setting-specific translated instrument in German care settings (PELI-D)Tobias Ingo Stacke, Johannes Michael Bergmann, Armin Michael Ströbel, et al.
The Journal of Experimental Medicine|November 5, 2016
--LUBAC deficiency perturbs TLR3 signaling to cause immunodeficiency and autoinflammationJulia Zinngrebe, Eva Rieser, Lucia Taraborrelli, et al.
Annals of Surgery|August 7, 2018
Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for Colorectal Cancer Liver MetastasisJagdeep Singh Bhangu, Andrea Beer, Martina Mittlböck, et al.
Nature Communications|March 16, 2025
Milestone in predicting core plasma turbulence: successful multi-channel validation of the gyrokinetic code GENEKlara Höfler, Tobias Görler, Tim Happel, et al.
Plos One|March 9, 2018
A randomized controlled trial-based algorithm for insulin-pump therapy in hyperglycemic patients early after kidney transplantationJohannes M Werzowa, Marcus D Säemann, Alexander Mohl, et al.
Annals of Surgery|March 30, 2002
TP53 genotype but not p53 immunohistochemical result predicts response to preoperative short-term radiotherapy in rectal cancerDaniela Kandioler, Ronald Zwrtek, Carmen Ludwig, et al.
Nature Communications|August 13, 2024
Dysfunctional tumor-infiltrating Vδ1 + T lymphocytes in microsatellite-stable colorectal cancerVictoria Stary, Ram V Pandey, Julia List, et al.
Pageof 15